HER2 Positive Breast Cancer : Reviewing Abstracts Published by Authors Anna van der Voort & Javier Cortes
HER2 Positive Breast Cancer
Speaker :
Dr. Seema Gulia, Medical Oncologist, Mumbai
Three-year follow-up of neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2-blockade for HER2-positive breast cancer (TRAIN-2): A randomized phase III trial
Author: Anna van der Voort
Citation :ASCO Abstract 501
Chemotherapy (CT) de-escalation using an FDG-PET/CT (F-PET) and pathological response-adapted strategy in HER2[+] early breast cancer (EBC): PHERGain Trial
Author: Javier Cortes
Citation: ASCO Abstract 503